title: Xanthohumol, the chalcone from beer hops (Humulus lupulus L.), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-A(y) mice.
abstract: We have examined the modulating action of xanthohumol (XN) on the farnesoid X receptor (FXR) in vitro and in vivo. In the transient transfection assay, XN dose-dependently increased the BSEP promoter-driven luciferase activity. XN-fed KK-A(y) mice exhibited lowered levels of plasma glucose, plasma, and hepatic triglyceride. They also showed decreased amounts of water intake, lowered weights of white adipose tissue, and exhibited increased levels of plasma adiponectin, indicating that XN attenuated diabetes in KK-A(y) mice. The hepatic gene expression of XN-fed mice showed lowered levels of SREBP-1c including its targets involved in fatty acid synthesis and lowered levels of gluconeogenetic genes. However, the expression of cholesterol 7-hydroxylase (CYP7A1) was significantly induced in the liver of XN-fed mice. From the present results, it is suggested that XN acts on FXR through a selective bile acid receptor modulator (SBARM) like guggulsterone or polyunsaturated fatty acids, which have previously been reported as SBARMs.
authors.affiliation: R&D Laboratory, Functional Food Division, Kirin Brewery Co., Ltd., 3 Miyahara, Takasaki, Gunma 370-1295, Japan. h-nozawa@kirin.co.jp
authors.forename: Hajime
authors.initials: H
authors.lastname: Nozawa
mesh_terms: D052242:Adiponectin; D000273:Adipose Tissue / Q000473:pathology; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D045744:Cell Line, Tumor; D047188:Chalcones / Q000737:chemistry / Q000494:pharmacology; D002635:Chenodeoxycholic Acid / Q000494:pharmacology; D004268:DNA-Binding Proteins / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000378:metabolism* / Q000473:pathology; D005419:Flavonoids; D015870:Gene Expression / Q000187:drug effects; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D027582:Humulus / Q000737:chemistry; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D036341:Intercellular Signaling Peptides and Proteins / Q000097:blood; D008024:Ligands; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D008820:Mice, Obese; D011427:Propiophenones / Q000737:chemistry / Q000494:pharmacology*; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors / Q000378:metabolism*; D014280:Triglycerides / Q000097:blood / Q000378:metabolism; D000099150:Receptor, Farnesoid X-Activated
chemical_list: D052242:Adiponectin; D001786:Blood Glucose; D047188:Chalcones; D002635:Chenodeoxycholic Acid; D004268:DNA-Binding Proteins; D005419:Flavonoids; D005947:Glucose; D007004:Hypoglycemic Agents; D036341:Intercellular Signaling Peptides and Proteins; D008024:Ligands; D011427:Propiophenones; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors; D014280:Triglycerides; D000099150:Receptor, Farnesoid X-Activated; C104536:xanthohumol